Poolbeg Pharma plc (LON:POLB), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, has appointed Singer Capital Markets as Joint Broker with immediate effect. finnCap Ltd will continue to act as Nominated Adviser and Joint Broker alongside J&E Davy as additional Joint Broker.

AI-driven biotech breakthroughs power Poolbeg Pharma
Poolbeg Pharma is a cutting-edge biotech company with high-value therapeutic programmes and AI-led drug discovery, appealing to forward-thinking investors.